Cytokinetics CYTK
NASDAQ CYTK
$63.95 +1.30 (+2.08%)
At close: Oct 20, 2026 · 4:00 PM EDT

Cytokinetics (CYTK) EV to EBITDA (2016 - 2017)

Updated

Cytokinetics' (CYTK) EV to EBITDA stood at 41.91 in Q1 2017, up 141.2% from the prior quarter.

Analysis

Cytokinetics (CYTK) EV to EBITDA (2016 - 2017) Analysis & Trends

On a TTM basis, Cytokinetics' EV to EBITDA came in at 3.12 as of Mar 31, 2017; for FY2016, it was 17.38.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Cytokinetics 8.46 Bn 4.63 Bn 25.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 41.91
Dec 31, 2016 17.38
Sep 30, 2016 110.82
API Access

Cytokinetics EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=CYTK&period=max&api_key=YOUR_API_KEY